Literature DB >> 10844137

Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae.

O Saetrum Opgaard1, P Hasbak, R de Vries, P R Saxena, L Edvinsson.   

Abstract

Isometric contractile force were studied on isolated human myocardial trabeculae that were paced at 1.0 Hz in tissue baths. Alpha calcitonin gene-related peptide (alpha-CGRP) had a potent positive inotropic effect in most trabeculae from both the right atrium and left ventricle, and this effect was partially antagonized by the CGRP(1) receptor antagonist alpha-CGRP-(8-37) (10(-6) M). Amylin and the CGRP(2) receptor agonist [Cys(acetylmethoxy)(2, 7)]CGRP had a positive inotropic effect in some trabeculae, whereas adrenomedullin had no inotropic effect. Using reverse transcriptase-polymerase chain reaction (PCR) mRNAs encoding the human calcitonin receptor-like receptor and the receptor associated modifying proteins (RAMPs) RAMP1, RAMP2, and RAMP3 were detected in human myocardial trabeculae from both the right atrium and left ventricle. In conclusion, functional CGRP(1) and CGRP(2) receptors may mediate a positive inotropic effect at both the atrial and ventricular level of the human heart. mRNAs for calcitonin receptor-like receptor and specific RAMPs further support the presence of CGRP receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844137     DOI: 10.1016/s0014-2999(00)00233-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  AM₁-receptor-dependent protection by intermedin of human vascular and cardiac non-vascular cells from ischaemia-reperfusion injury.

Authors:  David Bell; Malcolm Campbell; Matthew Ferguson; Leah Sayers; Liz Donaghy; Anna O'Regan; Victoria Jewhurst; Mark Harbinson
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

2.  Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling.

Authors:  Vince T Nguyen; Yewen Wu; Ashley N Guillory; Bradley K McConnell; Kenichi Fujise; Ming-He Huang
Journal:  Peptides       Date:  2011-11-15       Impact factor: 3.750

3.  Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling.

Authors:  N Paolocci; W F Saavedra; K M Miranda; C Martignani; T Isoda; J M Hare; M G Espey; J M Fukuto; M Feelisch; D A Wink; D A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart.

Authors:  Mustafa Al-Rubaiee; Pandu R Gangula; Richard M Millis; Robin K Walker; Nsini A Umoh; Valerie M Cousins; Miara A Jeffress; Georges E Haddad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

Review 5.  Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.

Authors:  Andrea Stephanie Link; Anikó Kuris; Lars Edvinsson
Journal:  J Headache Pain       Date:  2008-01-23       Impact factor: 7.277

Review 6.  Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.

Authors:  D Bell; B J McDermott
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 7.  Adrenomedullin and cardiovascular diseases.

Authors:  Hoi Kin Wong; Tommy Tsang Cheung; Bernard M Y Cheung
Journal:  JRSM Cardiovasc Dis       Date:  2012-08-10

8.  H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.

Authors:  Mirjam Eberhardt; Maria Dux; Barbara Namer; Jan Miljkovic; Nada Cordasic; Christine Will; Tatjana I Kichko; Jeanne de la Roche; Michael Fischer; Sebastián A Suárez; Damian Bikiel; Karola Dorsch; Andreas Leffler; Alexandru Babes; Angelika Lampert; Jochen K Lennerz; Johannes Jacobi; Marcelo A Martí; Fabio Doctorovich; Edward D Högestätt; Peter M Zygmunt; Ivana Ivanovic-Burmazovic; Karl Messlinger; Peter Reeh; Milos R Filipovic
Journal:  Nat Commun       Date:  2014-07-15       Impact factor: 14.919

Review 9.  Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.

Authors:  Abimael González-Hernández; Bruno A Marichal-Cancino; Jair Lozano-Cuenca; Jorge S López-Canales; Enriqueta Muñoz-Islas; Martha B Ramírez-Rosas; Carlos M Villalón
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

Review 10.  How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice.

Authors:  Cindy Tiseo; Raffaele Ornello; Francesca Pistoia; Simona Sacco
Journal:  J Headache Pain       Date:  2019-05-06       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.